Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

33.51
Delayed Data
As of Sep 03
 -1.41 / -4.04%
Today’s Change
18.23
Today|||52-Week Range
42.48
+69.24%
Year-to-Date

Today’s Trading

Previous close34.92
Today’s open35.28
Day’s range33.37 - 35.47
Volume251,635
Average volume (3 months)329,953
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+34.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio147.8
Price/Sales10.36
Price/Book10.24

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA+0.26+0.80%
MACKMerrimack Pharmaceut...+0.05+0.49%
DVAXDynavax Technologies...-1.21-4.16%
TXMDTherapeuticsMD Inc-0.13-2.08%
Data as of 4:01pm ET, 09/03/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers